Original Research

Published on 26 Mar 2021

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

in Cytokines and Soluble Mediators in Immunity

Francesca Caldarale
Mauro Giacomelli
Emirena Garrafa
Nicola Tamassia
Alessia Morreale
Piercarlo Poli
Silviana Timpano
Giulia Baresi
Fiammetta Zunica
Marco Cattalini

Frontiers in Immunology

doi 10.3389/fimmu.2021.654587

6,516 views
34 citations

Opinion

Published on 24 Mar 2021

Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins

in Cytokines and Soluble Mediators in Immunity

Masahiro Nishibori
Barbara S. Stonestreet

Frontiers in Immunology

doi 10.3389/fimmu.2021.656099

3,446 views
3 citations

Review

Published on 19 Mar 2021

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis

in Cytokines and Soluble Mediators in Immunity

Dennis McGonagle
Abdulla Watad
Kassem Sharif
Charlie Bridgewood

Frontiers in Immunology

doi 10.3389/fimmu.2021.614255

18,365 views
25 citations

Editorial

Published on 19 Mar 2021

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy

in Cytokines and Soluble Mediators in Immunity

Beatriz Martín-Antonio

Frontiers in Immunology

doi 10.3389/fimmu.2021.666703

2,777 views
2 citations

Original Research

Published on 19 Mar 2021

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

in Cytokines and Soluble Mediators in Immunity

Dan J. K. Yombo
Varshini Odayar
Nishant Gupta
Anil G. Jegga
Satish K. Madala

Frontiers in Immunology

doi 10.3389/fimmu.2021.645717

4,976 views
11 citations

Editorial

Published on 18 Mar 2021

Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis

in Cytokines and Soluble Mediators in Immunity

Fabrizio Antonangeli
Ola Grimsholm
Marianna Nicoletta Rossi
Francesca Velotti

Frontiers in Immunology

doi 10.3389/fimmu.2021.668876

2,398 views
2 citations

Review

Published on 16 Mar 2021

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

in Cytokines and Soluble Mediators in Immunity

Praxedis Martin
Jérémie D. Goldstein
Loïc Mermoud
Alejandro Diaz-Barreiro
Gaby Palmer

Frontiers in Immunology

doi 10.3389/fimmu.2021.652846

11,095 views
34 citations

Review

Published on 16 Mar 2021

ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization

in Cytokines and Soluble Mediators in Immunity

Jan Damoiseaux

Frontiers in Immunology

doi 10.3389/fimmu.2021.656796

8,908 views
5 citations

Review

Published on 15 Mar 2021

Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches

in Cytokines and Soluble Mediators in Immunity

Alice Pievani
Roberto Savoldelli
Juliane Poelchen
Elisa Mattioli
Giorgio Anselmi
Alice Girardot
Jochen Utikal
Pierre Bourdely
Marta Serafini
Pierre Guermonprez

Frontiers in Immunology

doi 10.3389/fimmu.2021.631279

5,569 views
5 citations

Original Research

Published on 11 Mar 2021

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8

in Cytokines and Soluble Mediators in Immunity

Mieke Metzemaekers
Sara Abouelasrar Salama
Jennifer Vandooren
Anneleen Mortier
Rik Janssens
Sofie Vandendriessche
Eva Ganseman
Erik Martens
Mieke Gouwy
Barbara Neerinckx

Frontiers in Immunology

doi 10.3389/fimmu.2021.644725

6,039 views
9 citations

Original Research

Published on 09 Mar 2021

Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock

in Cytokines and Soluble Mediators in Immunity

Rainer König
Amol Kolte
Olaf Ahlers
Marcus Oswald
Veiko Krauss
Daniela Roell
Oliver Sommerfeld
George Dimopoulos
Iraklis Tsangaris
Eleni Antoniadou

Frontiers in Immunology

doi 10.3389/fimmu.2021.607217

4,865 views
16 citations

Original Research

Published on 09 Mar 2021

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

in Cytokines and Soluble Mediators in Immunity

Marco Contoli
Alberto Papi
Luca Tomassetti
Paola Rizzo
Francesco Vieceli Dalla Sega
Francesca Fortini
Francesca Torsani
Luca Morandi
Luca Ronzoni
Ottavio Zucchetti

Frontiers in Immunology

doi 10.3389/fimmu.2021.648004

11,011 views
51 citations

Original Research

Published on 08 Mar 2021

ADP-Ribosylation Regulates the Signaling Function of IFN-γ

in Cytokines and Soluble Mediators in Immunity

Stephan Menzel
Tomas Koudelka
Björn Rissiek
Friedrich Haag
Catherine Meyer-Schwesinger
Andreas Tholey
Friedrich Koch-Nolte

Frontiers in Immunology

doi 10.3389/fimmu.2021.642545

3,244 views
6 citations

Original Research

Published on 05 Mar 2021

Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism

in Cytokines and Soluble Mediators in Immunity

Masaaki Ishii
Gyda Beeson
Craig Beeson
Bärbel Rohrer

Frontiers in Immunology

doi 10.3389/fimmu.2021.628062

11,179 views
17 citations

Review

Published on 05 Mar 2021

Perspectives on the Genetic Associations of Ankylosing Spondylitis

in Cytokines and Soluble Mediators in Immunity

B. Paul Wordsworth
Carla J. Cohen
Connor Davidson
Matteo Vecellio

Frontiers in Immunology

doi 10.3389/fimmu.2021.603726

7,804 views
14 citations

Original Research

Published on 04 Mar 2021

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt

in Cytokines and Soluble Mediators in Immunity

Renée H. Fiechter
Henriëtte M. de Jong
Leonieke J. J. van Mens
Inka A. Fluri
Sander W. Tas
Dominique L. P. Baeten
Nataliya G. Yeremenko
Marleen G. H. van de Sande

Frontiers in Immunology

doi 10.3389/fimmu.2021.611656

5,095 views
17 citations

Navigation group

Articles

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome

Understanding of COVID-19 Pathology: Much More Attention to Plasma Proteins

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

Editorial: Cellular Stress and Inflammation: How the Immune System Drives Tissue Homeostasis

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization

Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8

Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic Shock

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

ADP-Ribosylation Regulates the Signaling Function of IFN-γ

Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism

Perspectives on the Genetic Associations of Ankylosing Spondylitis

IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt